Foghorn Therapeutics (NASDAQ:FHTX) Announces Earnings Results

Foghorn Therapeutics (NASDAQ:FHTX – Get Rating) issued its earnings results on Monday. The company reported ($0.73) EPS for the quarter, missing analysts’ consensus estimates of ($0.71) by ($0.02), MarketWatch Earnings reports. Foghorn Therapeutics had a negative net margin of 566.27% and a negative return on equity of 301.47%. The firm had revenue of $5.31 million […]

Related Keywords

United States ,America , ,Wells Fargo Company ,Foghorn Therapeutics Inc ,Tower Research Capital ,Barclays Plc ,Foghorn Therapeutics Company Profile ,America Corp ,Foghorn Therapeutics ,Get Rating ,Marketwatch Earnings ,Research Capital ,Therapeutics Inc ,Gene Traffic Control ,Foghorn Therapeutics Daily ,Nasdaq Fhtx ,Fhtx ,Medical ,Earnings ,